Related references
Note: Only part of the references are listed.IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase
Georg F. Weber et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge: Immune cells as sources and targets of the IL-10 family members?
K Wolk et al.
JOURNAL OF IMMUNOLOGY (2002)
Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma
Q Zhang et al.
JOURNAL OF IMMUNOLOGY (2002)
Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22
L Dumoutier et al.
JOURNAL OF IMMUNOLOGY (2001)
Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9
L Dumoutier et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
